Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
14.11.2022 - Carlsbad, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) - Palisade Bio, Inc., (Nasdaq: PALI) a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications (the “Company” or “Palisade”), reported its ...
Source: wallstreet-online.de